P240028/S006: WiSE (Wireless Stimulation of the Endocardium Technology) CRT System
FDA’s recorded scope: qualification of a new supplier for the IrOx coating process on the needle tip of the WiSE CRT System
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name EBR Systems, Inc.. 1 entry is a PMA supplement. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 3, 2025 to Mar 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code SEG appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P240028, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 480 Oakmead Pkwy., Sunnyvale, CA, 94085. Recorded on P240028/S006, decision dated Mar 27, 2026.
Leadless Cardiac Resynchronization Therapy (CRT).
FDA’s recorded scope: qualification of a new supplier for the IrOx coating process on the needle tip of the WiSE CRT System
FDA’s recorded scope: to update manufacturing lot release testing requirements for M1000 and M2000 catheters.
FDA’s recorded scope: approval for an additional energy calibration inspection for the Transmitter subassembly
FDA’s recorded scope: additional wire bonder equipment
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| EBR Systems, Inc. | PMA supplement | Mar 27, 2026 | FDA | |
| EBR Systems, Inc. | PMA supplement | Dec 15, 2025 | FDA | |
| EBR Systems, Inc. | PMA supplement | Oct 3, 2025 | FDA | |
| EBR Systems, Inc. | PMA supplement | Sep 3, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.